Medfinder
Back to blog

Updated: January 19, 2026

Bisacodyl Shortage: What Providers and Prescribers Need to Know in 2026

Author

Peter Daggett

Peter Daggett

Provider reviewing Bisacodyl shortage data with stethoscope

A 2026 clinical briefing on Bisacodyl availability for providers: shortage status by formulation, prescribing implications for bowel prep, and alternative protocols.

If your patients have reported difficulty finding bisacodyl suppositories — particularly for colonoscopy or surgical bowel preparation — the supply disruption they're encountering is real and clinically significant. This briefing outlines the current supply landscape, the clinical contexts most affected, alternative protocols, and practical tools for supporting your patients through the shortage.

Current Supply Status by Formulation (2026)

Oral tablets (5 mg, enteric-coated): No current shortage. Multiple manufacturers supply this form. Widely available at all pharmacy channels. Cash price $2–$8 for 25–100 count.

Rectal suppositories (10 mg): Intermittently available. G&W Laboratories exited the market, reducing supply. Perrigo, Major Pharmaceuticals, Geri-Care, and Rugby continue production but have not fully compensated for the gap. ASHP Drug Shortage Database has reflected this disruption at various points. Periodic spot shortages at chain pharmacies remain common.

Rectal enemas (10 mg): Limited availability. Fleet continues some production, but this form is less commonly stocked.

Clinical Contexts Most Affected

Colonoscopy and endoscopic bowel preparation. Bisacodyl suppositories are a standard component of many bowel prep protocols, particularly split-dose and same-day preparation regimens. If your standard protocol includes a bisacodyl suppository on the morning of the procedure, advise patients to confirm suppository availability at their dispensing pharmacy at least 5–7 days prior.

Preoperative bowel preparation. Similar considerations apply to surgical prep protocols that include bisacodyl. Consider proactively confirming suppository availability or having an alternative protocol ready.

Neurogenic bowel management. Patients with spinal cord injury, multiple sclerosis, or other neurogenic bowel conditions often depend on bisacodyl suppositories as part of a structured bowel management program. The intermittent shortage creates particular disruption for this population. Proactive planning and identification of alternate suppliers is warranted.

Alternative Bowel Prep Protocols When Bisacodyl Suppositories Are Unavailable

When suppositories are not available, the following modifications are clinically reasonable for most standard colonoscopy prep regimens:

Substitute oral bisacodyl tablets: Oral tablets are widely available. If the protocol uses a 10 mg suppository the morning of the procedure, a 10–15 mg oral dose the evening before may be substituted in appropriate patients with guidance from your GI protocol team.

Switch to PEG-based prep: Polyethylene glycol-based preparations (GoLYTELY, MoviPrep, Suprep) provide effective bowel cleansing without bisacodyl. Note: Avoid co-administering sodium sulfate bowel preps with bisacodyl due to risk of ischemic colitis.

Senna substitution: Senna is a stimulant laxative with a similar mechanism and 6–12 hour oral onset. It can substitute for oral bisacodyl in many constipation management scenarios.

Key Drug Interactions Relevant to Bisacodyl

When prescribing or recommending bisacodyl, be aware of the following interactions:

Sodium sulfate bowel preps: Avoid co-administration — increased risk of mucosal ulceration and ischemic colitis. (Serious — Use Alternative)

Antacids / H2-receptor antagonists / PPIs: Premature dissolution of enteric coating — advise patients not to take bisacodyl within 1 hour of these agents.

Digoxin: Bisacodyl may reduce digoxin absorption; monitor serum digoxin levels in patients on concurrent therapy.

Diuretics / Corticosteroids: Increased electrolyte imbalance risk, particularly hypokalemia, with excessive bisacodyl use.

How to Help Patients Find Bisacodyl in Stock

When a patient reports being unable to fill bisacodyl suppositories, direct them to medfinder for Providers — a service that calls pharmacies on the patient's behalf to identify which ones have a medication in stock, texting results directly. For a full guide on supporting patients through stock issues, see our provider's guide to helping patients find Bisacodyl.

In general, advise patients to: call independent pharmacies (often better stocked than chains), request special orders from their pharmacy's wholesaler (1–2 day turnaround), and check online retailers for non-urgent OTC needs.

Frequently Asked Questions

Bisacodyl suppositories have appeared on the ASHP Drug Shortage Database due to manufacturer exits, most notably G&W Laboratories discontinuing their line. As of early 2026, the supply situation is improving but pharmacy-level spot shortages remain common. Bisacodyl oral tablets are not currently listed on any shortage database.

Clinically reasonable alternatives include oral bisacodyl tablets (10–15 mg the evening prior, per your protocol), switching to a fully PEG-based preparation (GoLYTELY, MoviPrep), or using senna for the stimulant laxative component. Always confirm with your GI team's prep guidelines before modifying standard protocols.

Yes. Bisacodyl should not be co-administered with sodium sulfate-containing bowel preps (e.g., Suprep, Clenpiq with sodium sulfate). Co-administration increases the risk of mucosal ulceration and ischemic colitis. PEG-based preps without sodium sulfate are generally considered safe when bisacodyl is used as directed in combination protocols.

Bisacodyl is commonly included in structured bowel management programs for neurogenic bowel dysfunction. While short-term use has an excellent safety profile, long-term daily use (beyond 4 weeks) requires monitoring for electrolyte imbalance, laxative dependence, and potential colonic changes. Collaborate with gastroenterology or physiatry for long-term neurogenic bowel management.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Bisacodyl also looked for:

Senna (Senokot, Ex-Lax)Polyethylene glycol 3350 (MiraLAX)Magnesium hydroxide (Milk of Magnesia)Docusate sodium (Colace)

30,026 have already found their meds with Medfinder.

Start your search today.

30K+
5-star ratingTrusted by 30,026 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?